Dr Andrea Scarpino

Andrea joined the ICR in July 2021 as a Postdoctoral Training Fellow. He previously received a Marie Skłodowska-Curie fellowship to work in the Medicinal Chemistry Team at the Research Centre for Natural Sciences in Budapest, where he completed his PhD focusing on the development of covalent docking protocols for drug discovery. Andrea is currently leading the research activities of the In Silico Medicinal Chemistry team in the Centre for Cancer Drug Discovery at the ICR. Andrea also contributes to research projects in the Centre for Protein Degradation (CPD) and Centre for Target Validation (CTV) by applying computational methods to support the design of targeted protein degraders and to assess the ligandability of targets in the CTV portfolio.